Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15497454rdf:typepubmed:Citationlld:pubmed
pubmed-article:15497454lifeskim:mentionsumls-concept:C0677607lld:lifeskim
pubmed-article:15497454lifeskim:mentionsumls-concept:C0021965lld:lifeskim
pubmed-article:15497454lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:15497454lifeskim:mentionsumls-concept:C0079600lld:lifeskim
pubmed-article:15497454lifeskim:mentionsumls-concept:C1709707lld:lifeskim
pubmed-article:15497454pubmed:issue3lld:pubmed
pubmed-article:15497454pubmed:dateCreated2004-10-22lld:pubmed
pubmed-article:15497454pubmed:abstractTextAutoantibodies to thyroid peroxidase (TPO) predominately recognise conformational epitopes, restricted to two immunodominant regions (IDR) -A and -B. We have estimated the proportion of IDR-A and -B autoantibodies in 75 Hashimoto and 68 Graves patients sera. There were no statically significant differences between Hashimoto and Graves patients sera in the IDR-A and -B autoantibodies level, despite great differences between individual patients sera. In 75 Hashimoto patients sera, the mean value of IDR-A was 24.26%, IDR-B--52.26%, IDR (A + B)-76.66%, and to non-A, non-B regions--23.5%. In 68 Graves disease patients, the mean value of IDR-A was 24.87, IDR-B--54.29, IDR (A + B)--79.07, non-A, non-B--20.92%, at a single autoantibodies concentration 5IU/ml. At high autoantibodies concentration (50 IU/ml) the proportion of autoantibodies to the IDR (A + B) diminished to 58% and to the non-A, non-B TPO regions increased to 42%. The autoimmune response to TPO regions outside the IDR (A + B) epitopes is stronger then previously assumed and this response is also conformation dependent.lld:pubmed
pubmed-article:15497454pubmed:languageenglld:pubmed
pubmed-article:15497454pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15497454pubmed:citationSubsetIMlld:pubmed
pubmed-article:15497454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15497454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15497454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15497454pubmed:statusMEDLINElld:pubmed
pubmed-article:15497454pubmed:monthMaylld:pubmed
pubmed-article:15497454pubmed:issn0891-6934lld:pubmed
pubmed-article:15497454pubmed:authorpubmed-author:GardasAndrzej...lld:pubmed
pubmed-article:15497454pubmed:authorpubmed-author:Jastrzebska-B...lld:pubmed
pubmed-article:15497454pubmed:issnTypePrintlld:pubmed
pubmed-article:15497454pubmed:volume37lld:pubmed
pubmed-article:15497454pubmed:ownerNLMlld:pubmed
pubmed-article:15497454pubmed:authorsCompleteYlld:pubmed
pubmed-article:15497454pubmed:pagination211-6lld:pubmed
pubmed-article:15497454pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:meshHeadingpubmed-meshheading:15497454...lld:pubmed
pubmed-article:15497454pubmed:year2004lld:pubmed
pubmed-article:15497454pubmed:articleTitleProportion of antibodies to the A and B immunodominant regions of thyroid peroxidase in Graves and Hashimoto disease.lld:pubmed
pubmed-article:15497454pubmed:affiliationMedical Centre of Postgraduate Education, Clinical Biochemistry Department, 01-813, Warsaw, Poland.lld:pubmed
pubmed-article:15497454pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15497454pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7173entrezgene:pubmedpubmed-article:15497454lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15497454lld:entrezgene